What is a stock summary page? Click here for an overview.
Business Description
Applied DNA Sciences Inc
NAICS : 541380
SIC : 2835
ISIN : US03815U2015
Description
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 15.31 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.05 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -29.19 | |||||
| Beneish M-Score | 0.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -67.7 | |||||
| 3-Year EBITDA Growth Rate | 53.4 | |||||
| 3-Year EPS without NRI Growth Rate | 54 | |||||
| 3-Year FCF Growth Rate | 57.2 | |||||
| 3-Year Book Growth Rate | -69.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 15.75 | |||||
| 9-Day RSI | 16.06 | |||||
| 14-Day RSI | 19.16 | |||||
| 3-1 Month Momentum % | -11.35 | |||||
| 6-1 Month Momentum % | -87.39 | |||||
| 12-1 Month Momentum % | -98.43 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.72 | |||||
| Quick Ratio | 4.53 | |||||
| Cash Ratio | 3.89 | |||||
| Days Inventory | 67.3 | |||||
| Days Sales Outstanding | 51.71 | |||||
| Days Payable | 197.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -208.7 | |||||
| Shareholder Yield % | -875.95 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.33 | |||||
| Operating Margin % | -353.13 | |||||
| Net Margin % | -228.09 | |||||
| FCF Margin % | -358.4 | |||||
| ROE % | -110.81 | |||||
| ROA % | -66.05 | |||||
| ROIC % | -239.82 | |||||
| 3-Year ROIIC % | -315.37 | |||||
| ROC (Joel Greenblatt) % | -928.4 | |||||
| ROCE % | -128.11 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.03 | |||||
| PB Ratio | 0.18 | |||||
| Price-to-Tangible-Book | 0.22 | |||||
| EV-to-EBIT | 0.52 | |||||
| EV-to-EBITDA | 0.54 | |||||
| EV-to-Revenue | -1.84 | |||||
| EV-to-Forward-Revenue | 0.26 | |||||
| EV-to-FCF | 0.5 | |||||
| Price-to-GF-Value | 0.07 | |||||
| Price-to-Net-Current-Asset-Value | 0.28 | |||||
| Price-to-Net-Cash | 0.37 | |||||
| Earnings Yield (Greenblatt) % | 192.31 | |||||
| FCF Yield % | -583.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:APDN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Applied DNA Sciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3.738 | ||
| EPS (TTM) ($) | -285.985 | ||
| Beta | 0.27 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.59 | ||
| Volatility % | 454.75 | ||
| 14-Day RSI | 19.16 | ||
| 14-Day ATR ($) | 0.689283 | ||
| 20-Day SMA ($) | 5.047505 | ||
| 12-1 Month Momentum % | -98.43 | ||
| 52-Week Range ($) | 1.67 - 506.4 | ||
| Shares Outstanding (Mil) | 1.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Applied DNA Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Applied DNA Sciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Applied DNA Sciences Inc Frequently Asked Questions
What is Applied DNA Sciences Inc(APDN)'s stock price today?
The current price of APDN is $2.08. The 52 week high of APDN is $506.40 and 52 week low is $1.67.
When is next earnings date of Applied DNA Sciences Inc(APDN)?
The next earnings date of Applied DNA Sciences Inc(APDN) is 2025-05-09 Est..
Does Applied DNA Sciences Inc(APDN) pay dividends? If so, how much?
Applied DNA Sciences Inc(APDN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers